McAleese & Associates: Boeing’s Defense Segment Posted $7B in Q3 Sales

Jeff Brody
Jim McAleese

A new McAleese & Associates report says Boeing’s (NYSE: BA) defense, space and security business recorded $7B in sales during the second quarter of 2019, reflecting a 2 percent increase from the prior-year period.

Jim McAleese, founder and principal of McAleese & Associates and a 2019 Wash100 winner, wrote the BDS business saw its profit rise 406 percent to $755M with an operating margin of 10.7 percent driven by a range of deliveries during the quarter.

Those deliveries include the AH-64 and CH-47 helicopters for the U.S. Army, KC-46 tanker planes for the U.S. Air Force and P-8 military aircraft for the U.S. Navy.

Boeing said Wednesday its defense business posted a backlog of $62B, of which 30 percent accounts for orders from international clients.

The company mentioned several Q3 milestones, including the completion of the initial flight test of the MQ-25 unmanned aerial refueling aircraft; the 100th flight test of the T-7A Red Hawk jet trainer; and final assembly of the Space Launch System’s core-stage structure.

Boeing’s global services sector saw its Q2 sales jump 14 percent to $4.7B, driven by higher volume in government services and acquisition of KLX, which now operates as Boeing Distribution Services. The segment’s profit climbed 23 percent to $673M with a Q3 operating margin of 14.4 percent.

In the third quarter, the global services segment also secured contracts from the Air Force for KC-46A tanker lot 5 services, A-10 Thunderbolt II re-winging support and F-15 training to Qatar.

Check Also


Washington Headquarters Services Issues RFP for Acquisition Directorate Support Recompete

The Washington Headquarters Services has kicked off solicitations for the recompete of a multiple-award, indefinite-delivery/indefinite-quantity contract for analytic and technical support services to the WHS' acquisition directorate.

Liz Porter Health Group President Leidos

Leidos Promotes Liz Porter to Health Group President

Liz Porter, acting president of Leidos’ (NYSE: LDOS) health group since March, has been promoted to the position on a permanent basis. She will report directly to Roger Krone, chairman and CEO of Leidos and a 2020 Wash100 Award recipient.